Beneath the Fatty Liver: Screening for Bone, Muscle and Vitamin D Deficits and Risk-Tailored Rehabilitation in Young and Middle-Aged Patients with MASLD

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) in younger and middle-aged adults may coexist with abnormalities in bone mineral density, muscle mass and vitamin D status that are not routinely assessed. Objective: To examine these abnormalities and evaluate risk-tailored rehabilitation alongside standard treatment. Methods: In this prospective, controlled, parallel-group study, 111 participants were assessed: 91 patients aged 18–59 years with MASLD and 20 healthy controls. Patients received standard treatment (group I; n = 47) or standard treatment with a risk-tailored rehabilitation programme (group II; n = 44), with assessments over 12 months. Dual-energy X-ray absorptiometry, serum 25(OH)D, metabolic indices and liver measurements were used. Results: Reduced bone mineral density and vitamin D deficiency were each identified in 53.8% of patients, and low muscle mass in 24.2%. Lower vitamin D status was associated with less favourable bone, metabolic and hepatic indices. At 12 months, body weight decreased by 3.1% in group I and 7.3% in group II, CAP by 7.9% and 18.6%, and HOMA-IR by 20.9% and 44.4%, respectively. Serum 25(OH)D increased from 19.4 to 22.1 ng/mL in group I and from 18.9 to 34.6 ng/mL in group II. L1–L4 bone mineral density changed by −1.3% and +1.5%, respectively, without statistically significant within-group changes. Conclusion: The findings support further evaluation of integrated musculoskeletal screening and risk-tailored rehabilitation in MASLD.

Authors

Institutions

Publication Details

Journal
Asian Journal of Medicine and Health
Published
2026-11-19
DOI
https://doi.org/10.9734/ajmah/2026/v24i121475
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beneath the Fatty Liver: Screening for Bone, Muscle and Vitamin D Deficits and Risk-Tailored Rehabilitation in Young and Middle-Aged Patients with MASLD

Г. Н. Собирова, A. A. Khamrayev, M. B. Temirova
Asian Journal of Medicine and Health
Liver Disease Diagnosis and Treatment
article

Beneath the Fatty Liver: Screening for Bone, Muscle and Vitamin D Deficits and Risk-Tailored Rehabilitation in Young and Middle-Aged Patients with MASLD

Г. Н. Собирова, A. A. Khamrayev, M. B. Temirova
article en

Abstract

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) in younger and middle-aged adults may coexist with abnormalities in bone mineral density, muscle mass and vitamin D status that are not routinely assessed. Objective: To examine these abnormalities and evaluate risk-tailored rehabilitation alongside standard treatment. Methods: In this prospective, controlled, parallel-group study, 111 participants were assessed: 91 patients aged 18–59 years with MASLD and 20 healthy controls. Patients received standard treatment (group I; n = 47) or standard treatment with a risk-tailored rehabilitation programme (group II; n = 44), with assessments over 12 months. Dual-energy X-ray absorptiometry, serum 25(OH)D, metabolic indices and liver measurements were used. Results: Reduced bone mineral density and vitamin D deficiency were each identified in 53.8% of patients, and low muscle mass in 24.2%. Lower vitamin D status was associated with less favourable bone, metabolic and hepatic indices. At 12 months, body weight decreased by 3.1% in group I and 7.3% in group II, CAP by 7.9% and 18.6%, and HOMA-IR by 20.9% and 44.4%, respectively. Serum 25(OH)D increased from 19.4 to 22.1 ng/mL in group I and from 18.9 to 34.6 ng/mL in group II. L1–L4 bone mineral density changed by −1.3% and +1.5%, respectively, without statistically significant within-group changes. Conclusion: The findings support further evaluation of integrated musculoskeletal screening and risk-tailored rehabilitation in MASLD.

Asian Journal of Medicine and HealthVol. 24(12)
Tashkent Pediatric Medical Institute (UZ), Tashkent State Medical University (UZ)
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon